- Conditions
- Asthma
- Interventions
- Fluticasone propionate, Placebo, BI 54903
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 41
- States / cities
- Fountain Valley, California • Huntington Beach, California • Long Beach, California + 36 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 74
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Exercise-induced Bronchospasm
- Interventions
- albuterol aerosol by HFA MDI, albuterol aerosol by HFA BOI, placebo aerosol by HFA
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years to 40 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004
- U.S. locations
- 3
- States / cities
- Denver, Colorado • Englewood, Colorado • Lakewood, Colorado
- Conditions
- Asthma
- Interventions
- levalbuterol tartrate HFA inhalation aerosol, placebo
- Drug
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Eligibility
- Up to 48 Months
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 17
- States / cities
- St. Petersburg, Florida • DeKalb, Illinois • Nicholasville, Kentucky + 12 more
- Conditions
- Asthma
- Interventions
- Ciclesonide, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 4 Years to 11 Years
- Enrollment
- 528 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Healthy Adult Volunteers
- Interventions
- Drug: OP0201, Drug: Placebo
- Combination Product
- Lead sponsor
- Novus Therapeutics, Inc
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Asthma
- Interventions
- BI 671800, Placebo, Montelukast
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 243 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 6
- States / cities
- Denver, Colorado • North Dartmouth, Massachusetts • Plymouth, Minnesota + 3 more
- Conditions
- Asthma
- Interventions
- Placebo, UMEC, Fluticasone Furoate, Albuterol/salbutamol
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 425 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 19
- States / cities
- Tempe, Arizona • Rolling Hills Estates, California • Colorado Springs, Colorado + 15 more
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Arformoterol, Placebo
- Drug
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 841 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 73
- States / cities
- Birmingham, Alabama • Brimingham, Alabama • Jasper, Alabama + 61 more
- Conditions
- Asthma
- Interventions
- Fp MDPI, Flovent Diskus, albuterol/salbutamol, Placebo MDPI
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 909 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 129
- States / cities
- Homewood, Alabama • Goodyear, Arizona • Scottsdale, Arizona + 104 more
- Conditions
- Asthma
- Interventions
- GP MDI, BFF MDI, Placebo MDI
- Combination Product
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 4 Years to 11 Years
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 15
- States / cities
- Bakersfield, California • Lancaster, California • Long Beach, California + 12 more
- Conditions
- Asthma
- Interventions
- Mometasone furoate/formoterol fumarate (MFF), Formoterol fumarate 12 μg pMDI (F12M), Formoterol fumarate 12 μg DPI (F12D), Placebo to F12D, Placebo to F12M/MFF
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 5 Years to 11 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 6
- States / cities
- Mobile, Alabama • Huntington Beach, California • Orange, California + 3 more
- Conditions
- Migraine With Aura, Migraine Without Aura
- Interventions
- Dronabinol MDI
- Drug
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 65 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 29
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Anaheim, California + 23 more
- Conditions
- Asthma
- Interventions
- placebo, tiotropium Respimat® low dose, tiotropium Respimat® high dose, 50 mcg salmeterol HFA MDI
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 1,032 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 18
- States / cities
- Los Angeles, California • Stockton, California • Centennial, Colorado + 15 more
- Conditions
- Asthma
- Interventions
- Fluticasone propionate/formoterol fumarate 100/10, Fluticasone propionate 100, Formoterol fumarate 10, Placebo
- Drug
- Lead sponsor
- SkyePharma AG
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 475 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 47
- States / cities
- Pell City, Alabama • Scottsdale, Arizona • Cypress, California + 42 more
- Conditions
- Asthma
- Interventions
- FS MDPI, Fp MDPI, Placebo MDPI, albuterol/salbutamol, Beclomethasone dipropionate
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 787 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 76
- States / cities
- Birmingham, Alabama • Glendale, Arizona • Cypress, California + 64 more
- Conditions
- Asthma
- Interventions
- Ciclesonide (XRP1526)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 456 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Asthma
- Interventions
- Fluticasone propionate/Formoterol fumarate 250/10, Placebo, Fluticasone propionate/Formoterol fumarate 100/10, Fluticasone propionate 250, Formoterol fumarate 10
- Drug
- Lead sponsor
- SkyePharma AG
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 557 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 62
- States / cities
- Pell City, Alabama • Glendale, Arizona • Phoenix, Arizona + 53 more
- Conditions
- COPD Patients
- Interventions
- Symbicort, Formoterol turbohaler, Placebo for Symbicort pMDI, Placebo for Formoterol Turbohaler
- Drug · Other
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 40 Years to 95 Years
- Enrollment
- 2,026 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 224
- States / cities
- Andalusia, Alabama • Birmingham, Alabama • Foley, Alabama + 107 more
- Conditions
- Asthma
- Interventions
- Placebo MDPI, Albuterol MDPI
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 38
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Costa Mesa, California + 30 more
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Measure concentrations of CBD in spot urine collections from subjects treated with inhaled CBD, Determine the presence and concentration of CBD in subject's plasma with inhaled CBD
- Drug
- Lead sponsor
- Trinity Hypertension & Metabolic Research Institute
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Carrollton, Texas
- Conditions
- Exercise Induced Bronchospasm
- Interventions
- Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg, Placebo metered-dose inhaler
- Combination Product
- Lead sponsor
- Bond Avillion 2 Development LP
- Industry
- Eligibility
- 12 Years to 70 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 6
- States / cities
- Denver, Colorado • North Dartmouth, Massachusetts • St Louis, Missouri + 3 more
- Conditions
- Asthma
- Interventions
- ELLIPTA inhaler, Placebo Inhalation Aerosol (MDI)
- Device
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 288 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 15
- States / cities
- Huntington Beach, California • Newport Beach, California • Vista, California + 12 more
- Conditions
- Asthma
- Interventions
- Beclomethasone dipropionate BAI, Placebo BAI, albuterol/salbutamol 90 mcg, Beclomethasone dipropionate MDI, Placebo MDI
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 4 Years to 11 Years
- Enrollment
- 628 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 75
- States / cities
- Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more
- Conditions
- Bronchial Asthma
- Interventions
- 90 mcg Reference Product, 180 mcg Reference Product, 90 mcg Test Product, Placebo
- Drug
- Lead sponsor
- Cipla Ltd.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Denver, Colorado